InvestorsHub Logo
Followers 0
Posts 34
Boards Moderated 0
Alias Born 08/12/2009

Re: None

Tuesday, 03/02/2010 12:09:27 PM

Tuesday, March 02, 2010 12:09:27 PM

Post# of 4094
NEWS RELEASE
APH:TSX-V, APCSF:OTCBB March 2, 2010
ALDA receives Australian Patent for T36® Disinfectant
Vancouver, BC - ALDA Pharmaceuticals Corp. (APH:TSX-V, APCSF:OTCBB, "ALDA") is pleased to
announce that Australian Patent Number 2007237333 has been issued by the Australian Patent Office.
This new patent is a divisional of Australian Patent Number 2002322916 that was issued on January 10,
2008 and provides further protection for ALDA's T36® formulation until August 20, 2022. The
divisional patent includes claims to additional aspects of the T36® formulation, including the use of T36®
as a component of a personal lubricant, in a method of preventing or reducing the transmission of
sexually transmitted diseases including Herpes, Chlamydia and HIV and as a sanitizer or cleanser in the
form of creams, ointments and wipes. The divisional patent also includes claims to methods of
producing T36®.
Dr. Terrance Owen, President & CEO, states, "This new Australian patent is another important asset in
our intellectual property portfolio because it provides additional protection for T36®. It also ties in well
with our strategy of registering T36® for therapeutic applications and complements the more recent PCT
application which covers a number of additional therapeu tic applications.”
About ALDA Pharmaceuticals Corp.
ALDA is focused on the development of infection-control therapeutics derived from its patented T36®
technology. The company trades on the TSX Venture Exchange under the symbol APH and on the
OTCBB under the symbol APCSF. The Company is the Official Supplier of the Vancouver 2010
Olympic Winter Games, Vancouver 2010 Paralympic Winter Games, the Canadian Olympic Committee,
the 2010 Canadian Olympic Team and the 2012 Canadian Olympic Team for antiseptic hand sanitizer,
disinfectant and disinfectant cleaning products. The Company has also been selected as one of the TSX
Venture 50 companies in the Technology and Life Sciences sector for 2010.
Terrance G. Owen, Ph.D., MBA
President & CEO
ALDA Pharmaceuticals Corp.
www.aldacorp.com
Sales Management 604-521-8300
Diane Mann , Account Executive Extension 4 diane_mann@aldacorp.com
Tracy Haubrich, Account Manager Extension 7 tracy_haubrich@aldacorp.com
Steve Cozine, Account Manager Extension 6 steve_cozine@aldacorp.com
Retail Sales
London Drugs, Shoppers Drug Mart, T&T Supermarket, IGA Marketplace, Pharmasave

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.